The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 07, 2023
Filed:
Sep. 20, 2018
Applicant:
Mersana Therapeutics, Inc., Cambridge, MA (US);
Inventors:
Rebecca Mosher, Newton, MA (US);
Laura L. Poling, Acton, MA (US);
Donald A. Bergstrom, Winchester, MA (US);
Assignee:
Mersana Therapeutics, Inc., Cambridge, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/68 (2017.01); C07K 16/28 (2006.01); G01N 33/574 (2006.01); C07K 16/30 (2006.01); A61P 35/00 (2006.01); A61K 49/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6803 (2017.08); A61K 47/6849 (2017.08); A61K 47/6857 (2017.08); A61K 47/6869 (2017.08); A61K 47/6889 (2017.08); A61K 49/0004 (2013.01); A61P 35/00 (2018.01); C07K 16/28 (2013.01); C07K 16/30 (2013.01); G01N 33/574 (2013.01); G01N 33/57423 (2013.01); G01N 33/57449 (2013.01); G01N 33/57492 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/94 (2013.01); G01N 2800/52 (2013.01); G01N 2800/56 (2013.01);
Abstract
This disclosure provides reagents and methods of predicting the responsiveness of a patient to NaPi2b-targeted antibody-drug conjugates (e.g., NaPi2b-targeted antibody-polymer-drug conjugates).